Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Related Posts
Jack Dorsey dramatically scales back crypto ambitions for Block
Block said Thursday that it was “winding down” its TBD division, which had sought to create an open-source crypto development platform.
Shipping groups are starting to shy away from the Strait of Hormuz as Israel-Iran conflict rages on
The escalating Israel-Iran conflict has prompted shipowners to exercise an extra degree of caution in both the Red Sea and the Strait of Hormuz.
Procter & Gamble earnings beat estimates, but weak demand in China hurts sales
Procter & Gamble said volume fell in its Greater China market despite the earnings beat.